Suregraft 0.25 Tablet
Prescription Required
Product introduction
Suregraft 0.25 Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Suregraft 0.25 Tablet is used to prevent the body rejecting the organ that is transplanted and also to prevent cancer post organ transplant
Suregraft 0.25 Tablet is used to prevent the body rejecting the organ that is transplanted and also to prevent cancer post organ transplant
Uses of Suregraft Tablet
Benefits of Suregraft Tablet
In Prevention of organ rejection in transplant patients
Suregraft 0.25 Tablet is used with other medications to prevent organ transplant rejection. Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc. This medicine reduces the activity of a person's own immune system and prevents any such rejection.
In Treatment of Breast cancer
Suregraft 0.25 Tablet is used to treat breast cancer in postmenopausal women when other medicines have failed to show significant improvement. It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipple or changes in the shape or texture of the breast. Take is as advised to get maximum relief.
In Treatment of Pancreatic cancer
Pancreas are very essential for digestion of whatever you eat and also for metabolism of blood sugar levels as they produce the body’s natural insulin. This medicine will help to control pancreatic cancer, and will relieve the symptoms such as, lack of appetite or unexplained weight loss. Suregraft 0.25 Tablet helps to stop the action of those chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and healthier life.
In Treatment of Lung cancer
Suregraft 0.25 Tablet reduces the blood supply to the cancer cells and stops its growth. But, as it reduces the immunity, avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to. Take a healthy diet and keep taking the medicine as prescribed to get the full benefits.
In Treatment of Kidney cancer
Suregraft 0.25 Tablet is used to treat kidney cancer when other medicines have failed to work. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor’s instructions very carefully to recover. Take it as prescribed to get the maximum benefit.
Side effects of Suregraft Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Suregraft
- Weakness
- Sinus inflammation
- Infection
- Fever
- Cough
- Fatigue
- Stomatitis (Inflammation of the mouth)
- Otitis media (infection of ear)
- Diarrhea
- Upper respiratory tract infection
How to use Suregraft Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Suregraft 0.25 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Suregraft 0.25 Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Suregraft 0.25 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Suregraft 0.25 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Suregraft 0.25 Tablet may cause side effects which could affect your ability to drive.
As fatigue is a common side effect with Suregraft 0.25 Tablet and this may affect your ability to drive
As fatigue is a common side effect with Suregraft 0.25 Tablet and this may affect your ability to drive
Kidney
SAFE IF PRESCRIBED
Suregraft 0.25 Tablet is safe to use in patients with kidney disease. No dose adjustment of Suregraft 0.25 Tablet is recommended.
Liver
CAUTION
Suregraft 0.25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Suregraft 0.25 Tablet may be needed. Please consult your doctor.
Use of Suregraft 0.25 Tablet is not recommended in patients with severe liver disease.
Use of Suregraft 0.25 Tablet is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Suregraft 0.25 Tablet
₹49.8/Tablet
Advacan 0.25mg Tablet
Biocon
₹48.35/tablet
8% costlier
Certican 0.25mg Tablet
Novartis India Ltd
₹78.9/tablet
76% costlier
Evergraf 0.25mg Tablet
Panacea Biotec Ltd
₹57.9/tablet
29% costlier
Lanolimus 0.25mg Tablet
Mylan Pharmaceuticals Pvt Ltd
₹40.6/tablet
9% cheaper
Everomus 0.25mg Tablet
Zydus Cadila
₹75/tablet
67% costlier
Quick tips
- Suregraft 0.25 Tablet is given for the treatment of certain cancers and to prevent organ transplant rejection.
- Suregraft 0.25 Tablet may affect male or female fertility; consult your doctor if you are planning to have a child.
- Inform your doctor straight away if you think you are getting a sore throat or if you have a high temperature. This is because Suregraft 0.25 Tablet increases your risk of getting an infection.
- While you are taking Suregraft 0.25 Tablet do not take any vaccinations without talking to your doctor first.
- If you are having an operation or dental treatment, always tell the person carrying out the treatment that you are taking Suregraft 0.25 Tablet.
- Do not drink grapefruit juice while you are taking this medicine. This is because a chemical in grapefruit juice can interfere with the action of Suregraft 0.25 Tablet.
Fact Box
Chemical Class
Macrolide Lactams
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Immunosuppressant- mTOR inhibitors
Patient concerns
FAQs
Is any monitoring required while taking Suregraft 0.25 Tablet?
Regular monitoring is required while you are on Suregraft 0.25 Tablet. The doctor will advise blood tests to see the counts of red blood cells, white blood cells, and platelets since the counts may decrease during treatment with Suregraft 0.25 Tablet. Also, blood tests will be required to check your kidney function, liver function, blood glucose levels, and cholesterol levels.
What should I avoid while taking Suregraft 0.25 Tablet?
You should avoid grapefruit or grapefruit juice while taking Suregraft 0.25 Tablet. This is because taking them together may increase the levels of Suregraft 0.25 Tablet in your blood to harmful levels. Avoid the use of live vaccinations and any possible contact with individuals who have received live vaccinations.
What is the most important information I need to know about Suregraft 0.25 Tablet?
Suregraft 0.25 Tablet can cause serious side effects which include severe allergic reactions, angioedema, and kidney failure which can be severe and can lead to death. It is possible that you may develop an infection or problems related to lung such as breathing problems.
Is Suregraft 0.25 Tablet a chemotherapy?
Suregraft 0.25 Tablet is an anticancer medicine. It belongs to kinase inhibitor class of medicines. It works by reducing the blood supply to the tumor, which slows down the growth and spread of cancer cells.
How is Suregraft 0.25 Tablet administered?
Usually, Suregraft 0.25 Tablet is taken once or twice daily. The medicine should always either be taken with food or always be taken without food. Suregraft 0.25 Tablet should be swallowed whole with water and should not be crushed or chewed.
How long can you take Suregraft 0.25 Tablet?
There is no definite duration of treatment with Suregraft 0.25 Tablet. Suregraft 0.25 Tablet is continued till clinical benefit is seen or unacceptable toxicity or side effects occur.
How will I know that Suregraft 0.25 Tablet is shrinking my brain tumor?
The effect of Suregraft 0.25 Tablet in shrinking the size of tumor can only be checked by getting regular brain scans. It should be done as advised by your doctor and your treatment plan.
Is Suregraft 0.25 Tablet cytotoxic?
Yes, Suregraft 0.25 Tablet is cytotoxic against human cancer cells of breast, stomach, prostate, and kidneys (renal cell carcinoma).
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Krensky AM, Bennett WM, Vincenti F. Immunosuppressants, Tolerogens, and Immunostimulants. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1013.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 526.
- Everolimus. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2009 [revised Apr. 2018]. [Accessed 06 Apr. 2019] (online) Available from:
- Everolimus. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2011 [revised 12 Jul 2018]. [Accessed 22 Jan. 2019] (online) Available from:
Marketer details
Name: Hospimax Healthcare Pvt Ltd
Address: 109, First Floor, DDA Building No. 5 District Centre, Janakpuri New Delhi West Delhi DL 110058 IN
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹498
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT
Notify me